⌘K

Login Start Free

Home/Filings/4/0001209191-14-071504

4//SEC Filing

SALIX PHARMACEUTICALS LTD 4

Accession 0001209191-14-071504

CIK 0001009356operating

View on SEC.gov Company Profile

Filed

Nov 25, 7:00 PM ET

Accepted

Nov 26, 4:04 PM ET

Size

7.4 KB

Accession

0001209191-14-071504

Insider Transaction Report

Form 4

Period: 2014-11-24

SALIX PHARMACEUTICALS LTDSLXP

CHAPPELL JOHN F

Director

Transactions

Exercise/Conversion
Common Stock
2014-11-24$17.63/sh+15,000$264,450→ 294,120 total
Exercise/Conversion
Option to Buy Common Stock
2014-11-24+15,000→ 0 total
Exercise: $17.63Exp: 2015-06-09→ Common Stock (15,000 underlying)

Holdings

Common Stock
(indirect: By Spouse)
28,644

Footnotes (1)

[F1]Options are 100% vested.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

SALIX PHARMACEUTICALS LTD

CIK 0001009356

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001009356

Filing Metadata

Form type: 4
Filed: Nov 25, 7:00 PM ET
Accepted: Nov 26, 4:04 PM ET
Size: 7.4 KB

View on SEC.gov